Meltem Zeytinoglu is an Endocrinology/Metabolic physician affiliated with Eli Lilly. OpenAlex indexes 24 publications with 313 citations (h-index 9).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
9977 Woods Dr
Skokie, IL 600771057
Telephone
847-663-8540Provider last certified this registry record 16 Dec 2025.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- PFIZER INC.Program year20251 payment
- Novo Nordisk IncProgram year20221 payment
- Novo Nordisk IncProgram year20211 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Tirzepatide Versus Intensified Conventional Care After 2 Years of Treatment in Early Type 2 Diabetes
Annals of Internal Medicine
2026 - Striving for early effective glycaemic and weight management in type 2 diabetes: A narrative review
Diabetes Obesity and Metabolism
2025 - Tirzepatide Improved Markers of Islet Cell Function and Insulin Sensitivity in People With T2D (SURPASS-2)
The Journal of Clinical Endocrinology & Metabolism
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Flora Sam, MD
Eli Lilly
Alessandro Biffi, MD
Eli Lilly
Ann Hake, MD
Eli Lilly
Kevin Biglan, MD
Eli Lilly
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”